COMMUNIQUÉ DE PRESSE publié le 05/11/2025 à 14:15, il y a 11 mois 29 jours Agereh Cancels Previously Announced Non-Brokered Private Placement and Announces Proposed New Private Placement and Issuance of Stock Options Agereh Technologies Inc. announces withdrawal of previous private placement plan and introduces new private placement offering $500,000 for 7,407,407 units. The company also issues stock options to directors Stock Options Private Placement AI Technology Transportation Industry Agereh Technologies Inc.
COMMUNIQUÉ DE PRESSE publié le 05/11/2025 à 14:05, il y a 11 mois 29 jours Thoughtworks Technology Radar Highlights The Rapid Evolution of AI Assistance in 2025 Thoughtworks releases Technology Radar Volume 33, highlighting the rapid evolution of AI assistance and key industry trends for 2025 Évolution 2025 AI Assistance Technology Radar Thoughtworks
COMMUNIQUÉ DE PRESSE publié le 05/11/2025 à 14:00, il y a 11 mois 29 jours TeamViewer reports rapid customer adoption of its Al offering TeamViewer reports rapid customer adoption of its AI offering, showcasing 400% growth in active users since July. The AI solution speeds up issue resolution by 25% AI TeamViewer Efficiency Gains IT Support Customer Adoption
COMMUNIQUÉ DE PRESSE publié le 05/11/2025 à 14:00, il y a 11 mois 29 jours Loar Holdings Inc. Announces Date and Time for Third Quarter 2025 Earnings Conference Call Loar Holdings Inc. (NYSE:LOAR) to report Q3 2025 earnings on November 12, 2025. Conference call details provided. Company overview and contact information included Conference Call Loar Holdings Inc. NYSE:LOAR Aerospace And Defense Q3 2025 Earnings
COMMUNIQUÉ DE PRESSE publié le 05/11/2025 à 14:00, il y a 11 mois 29 jours Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease Bausch Health and OraPharma expand commercial operations into Canada and Puerto Rico, aiming to enhance periodontal care access and strengthen partnerships with dental professionals Puerto Rico Bausch Health Canada OraPharma Periodontal Care
COMMUNIQUÉ DE PRESSE publié le 05/11/2025 à 13:46, il y a 11 mois 29 jours Informations privilégiées / Autres communiqués Poxel publie un second document en réponse aux questions des actionnaires pour renforcer la transparence et le dialogue. Découvrez les thématiques abordées Gouvernance Actionnaires Transparence Dialogue Poxel
COMMUNIQUÉ DE PRESSE publié le 05/11/2025 à 13:46, il y a 11 mois 29 jours Inside Information / Other news releases Poxel releases second document addressing shareholders' questions, emphasizing transparency and dialogue. Document covers trusts, financing, debts, stock market, and shareholders Shareholders Transparency Dialogue Document Poxel
COMMUNIQUÉ DE PRESSE publié le 05/11/2025 à 13:46, il y a 11 mois 29 jours Informations privilégiées / Autres communiqués Medincell annonce la poursuite de la croissance d'UZEDY® et la préparation du dépôt de l'Olanzapine LAI sur le marché américain par Teva Pharmaceuticals Croissance Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
COMMUNIQUÉ DE PRESSE publié le 05/11/2025 à 13:46, il y a 11 mois 29 jours Inside Information / Other news releases Medincell's partner Teva plans US NDA submission for Olanzapine LAI in Q4 2025, while UZEDY® achieves continued growth in sales in Q3 2025 Medincell Teva Pharmaceuticals Olanzapine LAI US NDA Submission UZEDY Sales Growth
COMMUNIQUÉ DE PRESSE publié le 05/11/2025 à 13:45, il y a 11 mois 29 jours Electrovaya Inc. Announces Pricing of Oversubscribed US$24.4 Million Public Offering of Common Shares Electrovaya Inc. announces pricing of public offering of Common Shares, granting underwriters option. Proceeds, underwriters, and use of funds outlined. Offering accessible via SEDAR+ and EDGAR Electrovaya Inc. Common Shares Underwriters Public Offering SEDAR+ And EDGAR
Publié le 04/11/2026 à 18:00, il y a 9 heures 32 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 9 heures 32 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 9 heures 48 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 4 heures 22 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 4 heures 32 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 5 heures 17 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 5 heures 27 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 03:10, il y a 22 minutes SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Publié le 05/11/2026 à 00:02, il y a 3 heures 29 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 7 heures 50 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 8 heures 7 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 8 heures 49 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year